These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4138250)

  • 61. [Etiology of Basedow's disease].
    Kumahara U; Fukuchi M
    Horumon To Rinsho; 1967 Oct; 15(10):834-40. PubMed ID: 4870889
    [No Abstract]   [Full Text] [Related]  

  • 62. Four controversies about the cause of hyperthyroidism.
    Munro DS; Humphries H; Hardisty CA; Brown Y; Hanford L
    Lancet; 1979 Aug; 2(8136):247-8. PubMed ID: 89351
    [No Abstract]   [Full Text] [Related]  

  • 63. The eye changes of Graves' disease: overview.
    Werner SC
    Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
    [No Abstract]   [Full Text] [Related]  

  • 64. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 65. Do heat shock proteins play a role in Graves' disease? Heat shock protein-specific T-cells from Graves' disease thyroids do not recognize thyroid epithelial cells.
    Trieb K; Sztankay A; Hermann M; Gratzl R; Szabo J; Jindal S; Grubeck-Loebenstein B
    J Clin Endocrinol Metab; 1993 Aug; 77(2):528-35. PubMed ID: 8345059
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Etiopathogenesis of thyrotoxicosis].
    de Medeiros Neto GA
    Rev Paul Med; 1967 Jan; 70(1):48-52. PubMed ID: 5631892
    [No Abstract]   [Full Text] [Related]  

  • 67. [The thyroid gland and autoimmunity].
    Fukase M; Torizuka K; Mori T; Morita R; Sakurami T
    Saishin Igaku; 1967 Jul; 22(7):1411-27. PubMed ID: 4868905
    [No Abstract]   [Full Text] [Related]  

  • 68. Relationships among immunoglobulin markers in Graves' disease.
    Ozawa Y; Maciel RM; Chopra IJ; Solomon DH; Beall GN
    J Clin Endocrinol Metab; 1979 Mar; 48(3):381-7. PubMed ID: 581874
    [No Abstract]   [Full Text] [Related]  

  • 69. Hypothyroidism with Graves' disease.
    Michaelson ED; Young RL
    JAMA; 1970 Feb; 211(8):1351-4. PubMed ID: 5467029
    [No Abstract]   [Full Text] [Related]  

  • 70. [Immunologic aspects of hyperthyreosis (author's transl)].
    Kośmider S; Kaszubowski P; Wysocki J
    Przegl Lek; 1980; 37(8):619-22. PubMed ID: 6999552
    [No Abstract]   [Full Text] [Related]  

  • 71. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves' ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith F
    Trans Assoc Am Physicians; 1976; 89():159-70. PubMed ID: 828344
    [No Abstract]   [Full Text] [Related]  

  • 72. The pathogenesis of hyperthyroidism.
    McKenzie JM
    Triangle; 1969; 9(1):2-8. PubMed ID: 5820145
    [No Abstract]   [Full Text] [Related]  

  • 73. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
    Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
    J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of the active severe eye changes of Graves' disease.
    Werner SC
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
    [No Abstract]   [Full Text] [Related]  

  • 75. Concepts of pathogenesis of Graves' disease.
    Solomon DH; Kleeman KE
    Adv Intern Med; 1977; 22():273-99. PubMed ID: 402796
    [No Abstract]   [Full Text] [Related]  

  • 76. Long-acting thyroid stimulator and exophthalmos.
    Burke G
    Ann Intern Med; 1969 May; 70(5):1045-6. PubMed ID: 4181434
    [No Abstract]   [Full Text] [Related]  

  • 77. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 78. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).
    Knox AJ; von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Autoimmunization symptoms in thyroid diseases].
    Wegier A; Głab S; Wróblewska I; Nowak M; Feluś E
    Pol Tyg Lek; 1978 Dec; 33(52):2011-3. PubMed ID: 366580
    [No Abstract]   [Full Text] [Related]  

  • 80. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
    Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
    Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.